With Hopes High for New H.I.V. Prevention Pill, Merck Takes Steps to Ensure Access
Source ↗
👁 0
💬 0
Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of Latin America remains uncertain.
Comments (0)